Study findings indicate that droplet digital polymerase chain reaction (ddPCR) may be more accurate than real-time quantitative PCR in measuring minimal residual disease (MRD) among pediatric patients ...
Droplet digital polymerase chain reaction (ddPCR) technology is emerging as an efficient, accurate, and precise way to measure transgene copy numbers. With it, scientists may screen for clonal ...
The study, using a BCR/ABL1 assay, found that the novel method is able to detect minimal residual disease (MRD) in a larger range of patients compared with quantitative real‐time polymerase chain ...
At this year’s American Society of Human Genetics annual meeting, Technology Networks caught up with Dr. Chelsea Pratt, biopharma segment manager at Bio-Rad Laboratories, who was exploring advances in ...
HERCULES, Calif., July 07, 2025--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the ...
Bio-Rad Laboratories BIO recently announced the launch of four new Droplet Digital PCR (ddPCR) platforms. The newly introduced instruments include the company's QX Continuum ddPCR system, along with ...
The ddPCR MSI assay can be completed in one day on a ddPCR-based platform to quantify the level of MSI present in colorectal tumors. Using either a blood or FFPE sample, the assay quantitatively ...
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), announced the launch of Vericheck ddPCR™ Empty-Full Capsid Kits for adenoassociated virus (AAV) serotypes 2 and 8, enabling determination of capsid ...
DPYD*7 as a Predictor of Severe Fluoropyrimidine-Related Adverse Events Patients with advanced solid tumors referred to the Department of Investigational Cancer Therapeutics at The University of Texas ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback